Roger Tsien, co-winner of the 2008 Nobel Prize in chemistry and professor of pharmacology, chemistry and biochemistry at University of California San Diego School of Medicine for 27 years, died Aug. 24 in Eugene, Ore. He was 64.
The Association of American Cancer Institutes and the White House Cancer Moonshot Task Force are developing a new method for funding research at academic cancer centers through private investment and philanthropy.
Cellectar Biosciences Inc. received the second phase of an NCI Fast-Track Small Business Innovation Research contract award of $2 million to support funding of a phase II study of the company’s lead product candidate, CLR 131, for the potential treatment of hematologic malignancies, including multiple myeloma. The award will help fund a multi-center, open label […]
Advanced Accelerator Applications and NCI formed a clinical trial agreement: NCI plans to sponsor and conduct a study of Lutathera in patients with inoperable pheochromocytoma and paraganglioma. Pheochromocytoma is a rare endocrine tumor originating in the adrenal glands. Paraganglioma is a tumor that is closely related to pheochromocytoma and originates from outside the adrenal glands. […]
FDA and the Centers for Medicare and Medicaid Services have accepted the FoundationOne comprehensive genomic profiling assay for parallel review. FDA also accepted Foundation Medicine’s request for review as part of its Expedited Access Pathway for breakthrough devices. If approved, the assay would be the first to incorporate multiple companion diagnostics to support precision medicine […]
FDA granted Breakthrough Therapy designation to LEE011 (ribociclib), in combination with letrozole, for the treatment of hormone receptor positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer. LEE011 is a selective cyclin dependent kinase (CDK4/6) inhibitor.
THE COMMUNITY ONCOLOGY ALLIANCE launched the Advanced Practice Provider Network, for oncology nurse practitioners, physician assistants and others. The network consists of a private, peer-to-peer-only information sharing website and listserv; monthly conference calls to review important practice issues and discuss solutions; and opportunities for in-person meetings. Participation in the network is open and free of […]
VANDERBILT-INGRAM CANCER CENTER received a $3 million, three-year grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, in support of VICC’s drug discovery program. “We are profoundly grateful to the Foundation for their support of this vitally important cancer drug discovery research initiative,” said Scott Hiebert, Hortense B. Ingram Professor of Cancer […]
UT SOUTHWESTERN MEDICAL CENTER's Harold C. Simmons Comprehensive Cancer Center received $11 million in SPORE funding from NCI to support its Kidney Cancer Program.
NATASCIA MARINO was named a Breast Cancer Research Foundation Investigator at the Indiana University School of Medicine. Marino, also an assistant research professor of medicine, is an investigator with the Susan G. Komen Tissue Bank at the IU Simon Cancer Center. Her research focuses on the normal breast and how it relates to the development […]
